APEX HealthCare ETF
APXH
APXH was delisted on the 24th of January, 2023.
4 hedge funds and large institutions have $5.54M invested in APEX HealthCare ETF in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
300% more funds holding
Funds holding: 1 → 4 (+3)
144% more capital invested
Capital invested by funds: $2.27M → $5.54M (+$3.27M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FIA
Foundations Investment Advisors
Phoenix,
Arizona
|
+$2.38M |
| 2 |
ACM
Anfield Capital Management
Irvine,
California
|
+$616K |
| 3 |
Jane Street
New York
|
+$231K |
| 4 |
JP Morgan Chase
New York
|
+$69.1K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FIA
1
Foundations Investment Advisors
Phoenix,
Arizona
| $4.61M | +$2.38M | +257,881 | +111% |
|
|
ACM
2
Anfield Capital Management
Irvine,
California
| $628K | +$616K | +66,904 | New |
|
|
3
Jane Street
New York
| $236K | +$231K | +25,104 | New |
|
|
4
JP Morgan Chase
New York
| $70K | +$69.1K | +7,499 | New |
|
APXH Hedge Fund Activity: Q1 2022 in Review
4 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in APEX HealthCare ETF (APXH) for Q1 2022, worth a combined $5.54M — up 144% from $2.27M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new APXH positions and 0 closed out — a net gain of 3 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Foundations Investment Advisors, adding an estimated $2.38M.
- 4 institutional investors held APEX HealthCare ETF (APXH) as of Q1 2022, up from 1 in Q4 2021.
- Funds reported $5.54M of APEX HealthCare ETF stock for Q1 2022, up 144% quarter-over-quarter.
- 3 funds opened new APEX HealthCare ETF positions in Q1 2022 and 0 closed out, a net change of +3 holders.
- The largest APEX HealthCare ETF buyer in Q1 2022 was Foundations Investment Advisors, an estimated $2.38M added.
Based on aggregated 13F filings for Q1 2022.